All data are based on the daily closing price as of February 6, 2026
s
Shinpoong Pharm
019170.KO
8.60 USD
-0.26
-2.93%
Overview
Last close
8.60 usd
Market cap
423.54M usd
52 week high
14.06 usd
52 week low
4.50 usd
Target price
3.94 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
2.7897
Price/Book Value
2.4662
Enterprise Value
435.68M usd
EV/Revenue
2.7492
EV/EBITDA
51.2842
Key financials
Revenue TTM
158.47M usd
Gross Profit TTM
66.32M usd
EBITDA TTM
6.75M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
243.87M usd
Net debt
5.85M usd
About
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.